首页> 外文期刊>Heart >Cardiac resynchronisation therapy in patients with chronic heart failure
【24h】

Cardiac resynchronisation therapy in patients with chronic heart failure

机译:慢性心力衰竭患者的心脏再同步治疗

获取原文
获取原文并翻译 | 示例
           

摘要

Cardiac resynchronisation therapy (CRT) is common treatment for congestive heart failure (HF) with decreased LV function and wide QRS complex. Its foundations are set in the understanding of the pathophysiology of ventricular dyssynchrony. Over the last several decades, CRT has evolved through changes in implantation techniques, device and lead design, imaging modalities and our growing clinical experience. This review article will discuss the vast clinical experience that has led to current guidelines recommendations for CRT in patients with mild-to-severe HF. In addition, the article will also discuss recent evidence of benefits of CRT in patients beyond the guidelines. The article will also address the issue of non-responders, optimisation of CRT, postimplant evaluation and remote monitoring.
机译:心脏再同步治疗(CRT)是充血性心力衰竭(HF)的常见治疗方法,其左室功能降低且QRS波复杂。它的基础是对心室不同步的病理生理学的了解。在过去的几十年中,CRT通过植入技术,设备和导线设计,成像方式以及我们不断发展的临床经验的变化而发展。这篇综述文章将讨论广泛的临床经验,这些经验已导致目前对轻度至重度HF患者进行CRT的指南建议。此外,本文还将讨论CRT对患者超出指南指导意义的最新证据。本文还将解决无响应者,CRT优化,植入后评估和远程监控的问题。

著录项

  • 来源
    《Heart》 |2015年第13期|1008-1014|共7页
  • 作者单位

    University of California, San Diego, California, USA;

    University of California, San Diego, 9300 Campus Point Drive, #7411, San Diego, CA 92037, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号